What anastrozole is and its FDA status
Anastrozole (Arimidex) is an aromatase inhibitor, a pill that blocks the enzyme that turns testosterone into estradiol, the main estrogen in both men and women. As of October 2026, its FDA label lists one population: postmenopausal women with breast cancer.
It is not approved for any use in men. When it shows up in a TRT plan, it is off-label, meaning a clinician has chosen to use it outside the approved indication. Off-label use is legal and sometimes reasonable, but it means the dose, the target and the long-term safety in men were never established by the trials that led to approval.
How does it lower estradiol?
Aromatase sits in fat tissue, the brain, bone and the testes, and it converts a small share of your testosterone into estradiol every day. Anastrozole binds that enzyme and shuts most of the conversion down. The label reports that a 1 mg dose cut estradiol by about 70 percent within 24 hours and about 80 percent after two weeks of daily use in the women studied.
That power is the problem in men. On testosterone therapy, estradiol usually rises along with testosterone, and that rise is mostly normal physiology rather than a disease. A drug that removes most estradiol can overshoot quickly, especially in men whose levels were not high to begin with.
Why is routine use on TRT discouraged?
No major guideline recommends adding an aromatase inhibitor to every TRT plan. The AUA guideline on testosterone deficiency asks clinicians to measure estradiol before treatment in men who have breast symptoms or gynecomastia, and it mentions aromatase inhibitors only as one option for men with low testosterone who want to preserve fertility. Using one as a default “estrogen control” step goes beyond that.
The reason is that men need estradiol. It helps keep bones strong, supports sex drive and erections, and influences where your body stores fat. Lowering it to prevent a side effect you do not have trades a possible problem for a likely one.
What happens when estradiol goes too low?
Research in men shows the costs clearly. In a controlled study in the New England Journal of Medicine, healthy men whose estradiol was blocked gained body fat, and both low testosterone and low estradiol contributed to declines in sexual function. In a year-long trial in men over 60, anastrozole raised testosterone but lowered spine bone density compared with placebo.
| Area | What low estradiol can do |
|---|---|
| Bones | Lower bone density over time, raising fracture risk |
| Joints | Aches and stiffness; joint pain is a common label side effect |
| Sex drive and erections | Reduced libido and weaker erections despite good testosterone |
| Body fat | More fat gain, especially around the middle |
| Mood | Mood changes are listed among the drug’s side effects |
| Cholesterol | The label lists increases in total cholesterol |
Some of these, such as low libido and fatigue, are the same symptoms that led to TRT in the first place, so a man can end up feeling worse while his estradiol “looks controlled.” Our page on low estradiol in men covers the pattern in more detail.
The sensitive estradiol test that guides any use
Any decision about estradiol starts with measuring it properly. Standard estradiol tests were built for the much higher levels seen in women and can be imprecise in the low range typical of men. A sensitive estradiol test, usually run by mass spectrometry, is more reliable, and our page on the sensitive estradiol test for men explains how to read it.
A useful workup pairs that number with symptoms, timing and the rest of the picture:
- Symptoms first. Tender or swelling breast tissue, water retention or mood swings carry more weight than a number on its own.
- Timing. Estradiol follows testosterone, so a draw at the peak after an injection reads higher than a trough.
- Body weight. More fat tissue means more aromatase and more conversion.
- Other causes. Liver disease, alcohol and some medicines can raise estradiol; see high estrogen in men.
When estradiol is high and symptoms fit, the first moves are usually to adjust the testosterone dose or schedule, address weight and alcohol, and recheck. Some clinicians consider a short, closely monitored course of an aromatase inhibitor in narrow situations, such as persistent breast symptoms with a confirmed high estradiol, with a plan to recheck and stop. Even there, expectations should be modest: in a placebo-controlled study the label describes, anastrozole did not outperform placebo for gynecomastia in adolescent boys.
Side effects and who should not take it
The label and MedlinePlus list hot flashes, weakness, joint pain and stiffness, mood changes and headache among common effects, plus bone loss and higher cholesterol with longer use. Anastrozole is a poor fit for men with osteoporosis or low bone density, men with high cholesterol or heart disease, and anyone allergic to it. It should not be combined with estrogen-containing products or tamoxifen.
Chest pain, sudden shortness of breath, one-sided weakness or a swollen, painful leg while on TRT or any added medicine needs a 911 call, not a clinic appointment.
How Ultimate Male handles estradiol on TRT
Anastrozole is not on Ultimate Male’s treatment menu. If you are already taking it, or a previous clinic added it, your provider will review why, check a sensitive estradiol and talk through bone health before deciding what to change. The clinic’s TRT pre-screening panel includes estradiol from the start, so there is a baseline to compare against.
From there, the tools are the ones on the menu: adjusting the testosterone therapy dose, schedule or form, such as testosterone cypionate injections split into smaller doses, and regular follow-up labs. Men weighing non-testosterone routes can compare clomiphene and enclomiphene. Start with a free 10-minute phone call at 626-319-5261.
